Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells

Acute promyelocytic leukemia (APL) is a hematological disease characterized by a balanced reciprocal translocation that leads to the synthesis of the oncogenic fusion protein PML-RARα. APL is mainly managed by a differentiation therapy based on the administration of all-<i>trans</i> reti...

Full description

Bibliographic Details
Main Authors: Jacopo Albanesi, Nelida Ines Noguera, Cristina Banella, Tommaso Colangelo, Elisabetta De Marinis, Stefano Leone, Orazio Palumbo, Maria Teresa Voso, Paolo Ascenzi, Clara Nervi, Fabrizio Bianchi, Alessandra di Masi
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/9/11/2423
_version_ 1797416485312790528
author Jacopo Albanesi
Nelida Ines Noguera
Cristina Banella
Tommaso Colangelo
Elisabetta De Marinis
Stefano Leone
Orazio Palumbo
Maria Teresa Voso
Paolo Ascenzi
Clara Nervi
Fabrizio Bianchi
Alessandra di Masi
author_facet Jacopo Albanesi
Nelida Ines Noguera
Cristina Banella
Tommaso Colangelo
Elisabetta De Marinis
Stefano Leone
Orazio Palumbo
Maria Teresa Voso
Paolo Ascenzi
Clara Nervi
Fabrizio Bianchi
Alessandra di Masi
author_sort Jacopo Albanesi
collection DOAJ
description Acute promyelocytic leukemia (APL) is a hematological disease characterized by a balanced reciprocal translocation that leads to the synthesis of the oncogenic fusion protein PML-RARα. APL is mainly managed by a differentiation therapy based on the administration of all-<i>trans</i> retinoic acid (ATRA) and arsenic trioxide (ATO). However, therapy resistance, differentiation syndrome, and relapses require the development of new low-toxicity therapies based on the induction of blasts differentiation. In keeping with this, we reasoned that a better understanding of the molecular mechanisms pivotal for ATRA-driven differentiation could definitely bolster the identification of new therapeutic strategies in APL patients. We thus performed an in-depth high-throughput transcriptional profile analysis and metabolic characterization of a well-established APL experimental model based on NB4 cells that represent an unevaluable tool to dissect the complex mechanism associated with ATRA-induced granulocytic differentiation. Pathway-reconstruction analysis using genome-wide transcriptional data has allowed us to identify the activation/inhibition of several cancer signaling pathways (e.g., inflammation, immune cell response, DNA repair, and cell proliferation) and master regulators (e.g., transcription factors, epigenetic regulators, and ligand-dependent nuclear receptors). Furthermore, we provide evidence of the regulation of a considerable set of metabolic genes involved in cancer metabolic reprogramming. Consistently, we found that ATRA treatment of NB4 cells drives the activation of aerobic glycolysis pathway and the reduction of OXPHOS-dependent ATP production. Overall, this study represents an important resource in understanding the molecular “portfolio” pivotal for APL differentiation, which can be explored for developing new therapeutic strategies.
first_indexed 2024-03-09T06:03:54Z
format Article
id doaj.art-0442c3793c73473e9c1fbc19d467ffbd
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-09T06:03:54Z
publishDate 2020-11-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-0442c3793c73473e9c1fbc19d467ffbd2023-12-03T12:05:26ZengMDPI AGCells2073-44092020-11-01911242310.3390/cells9112423Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia CellsJacopo Albanesi0Nelida Ines Noguera1Cristina Banella2Tommaso Colangelo3Elisabetta De Marinis4Stefano Leone5Orazio Palumbo6Maria Teresa Voso7Paolo Ascenzi8Clara Nervi9Fabrizio Bianchi10Alessandra di Masi11Dipartimento di Scienze, Sezione di Scienze e Tecnologie Biomediche, Università Roma Tre, 00146 Roma, ItalyDipartimento di Biomedicina e Prevenzione, Università di Tor Vergata, 00133 Roma, ItalyDipartimento di Biomedicina e Prevenzione, Università di Tor Vergata, 00133 Roma, ItalyFondazione IRCCS Casa Sollievo della Sofferenza, Cancer Biomarkers Unit, 71013 San Giovanni Rotondo (FG), ItalyDepartment of Medico-Surgical Sciences and Biotechnologies, University of Roma “La Sapienza”, 04100 Latina, ItalyDipartimento di Scienze, Sezione di Scienze e Tecnologie Biomediche, Università Roma Tre, 00146 Roma, ItalyFondazione IRCCS Casa Sollievo della Sofferenza, Division of Medical Genetics, 71013 San Giovanni Rotondo (FG), ItalyDipartimento di Biomedicina e Prevenzione, Università di Tor Vergata, 00133 Roma, ItalyDipartimento di Scienze, Sezione di Scienze e Tecnologie Biomediche, Università Roma Tre, 00146 Roma, ItalyDepartment of Medico-Surgical Sciences and Biotechnologies, University of Roma “La Sapienza”, 04100 Latina, ItalyFondazione IRCCS Casa Sollievo della Sofferenza, Cancer Biomarkers Unit, 71013 San Giovanni Rotondo (FG), ItalyDipartimento di Scienze, Sezione di Scienze e Tecnologie Biomediche, Università Roma Tre, 00146 Roma, ItalyAcute promyelocytic leukemia (APL) is a hematological disease characterized by a balanced reciprocal translocation that leads to the synthesis of the oncogenic fusion protein PML-RARα. APL is mainly managed by a differentiation therapy based on the administration of all-<i>trans</i> retinoic acid (ATRA) and arsenic trioxide (ATO). However, therapy resistance, differentiation syndrome, and relapses require the development of new low-toxicity therapies based on the induction of blasts differentiation. In keeping with this, we reasoned that a better understanding of the molecular mechanisms pivotal for ATRA-driven differentiation could definitely bolster the identification of new therapeutic strategies in APL patients. We thus performed an in-depth high-throughput transcriptional profile analysis and metabolic characterization of a well-established APL experimental model based on NB4 cells that represent an unevaluable tool to dissect the complex mechanism associated with ATRA-induced granulocytic differentiation. Pathway-reconstruction analysis using genome-wide transcriptional data has allowed us to identify the activation/inhibition of several cancer signaling pathways (e.g., inflammation, immune cell response, DNA repair, and cell proliferation) and master regulators (e.g., transcription factors, epigenetic regulators, and ligand-dependent nuclear receptors). Furthermore, we provide evidence of the regulation of a considerable set of metabolic genes involved in cancer metabolic reprogramming. Consistently, we found that ATRA treatment of NB4 cells drives the activation of aerobic glycolysis pathway and the reduction of OXPHOS-dependent ATP production. Overall, this study represents an important resource in understanding the molecular “portfolio” pivotal for APL differentiation, which can be explored for developing new therapeutic strategies.https://www.mdpi.com/2073-4409/9/11/2423acute promyelocytic leukemiaaerobic glycolysisall-trans-retinoic acidDNA repairepigenetic regulatorsimmune cell response
spellingShingle Jacopo Albanesi
Nelida Ines Noguera
Cristina Banella
Tommaso Colangelo
Elisabetta De Marinis
Stefano Leone
Orazio Palumbo
Maria Teresa Voso
Paolo Ascenzi
Clara Nervi
Fabrizio Bianchi
Alessandra di Masi
Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells
Cells
acute promyelocytic leukemia
aerobic glycolysis
all-trans-retinoic acid
DNA repair
epigenetic regulators
immune cell response
title Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells
title_full Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells
title_fullStr Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells
title_full_unstemmed Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells
title_short Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells
title_sort transcriptional and metabolic dissection of atra induced granulocytic differentiation in nb4 acute promyelocytic leukemia cells
topic acute promyelocytic leukemia
aerobic glycolysis
all-trans-retinoic acid
DNA repair
epigenetic regulators
immune cell response
url https://www.mdpi.com/2073-4409/9/11/2423
work_keys_str_mv AT jacopoalbanesi transcriptionalandmetabolicdissectionofatrainducedgranulocyticdifferentiationinnb4acutepromyelocyticleukemiacells
AT nelidainesnoguera transcriptionalandmetabolicdissectionofatrainducedgranulocyticdifferentiationinnb4acutepromyelocyticleukemiacells
AT cristinabanella transcriptionalandmetabolicdissectionofatrainducedgranulocyticdifferentiationinnb4acutepromyelocyticleukemiacells
AT tommasocolangelo transcriptionalandmetabolicdissectionofatrainducedgranulocyticdifferentiationinnb4acutepromyelocyticleukemiacells
AT elisabettademarinis transcriptionalandmetabolicdissectionofatrainducedgranulocyticdifferentiationinnb4acutepromyelocyticleukemiacells
AT stefanoleone transcriptionalandmetabolicdissectionofatrainducedgranulocyticdifferentiationinnb4acutepromyelocyticleukemiacells
AT oraziopalumbo transcriptionalandmetabolicdissectionofatrainducedgranulocyticdifferentiationinnb4acutepromyelocyticleukemiacells
AT mariateresavoso transcriptionalandmetabolicdissectionofatrainducedgranulocyticdifferentiationinnb4acutepromyelocyticleukemiacells
AT paoloascenzi transcriptionalandmetabolicdissectionofatrainducedgranulocyticdifferentiationinnb4acutepromyelocyticleukemiacells
AT claranervi transcriptionalandmetabolicdissectionofatrainducedgranulocyticdifferentiationinnb4acutepromyelocyticleukemiacells
AT fabriziobianchi transcriptionalandmetabolicdissectionofatrainducedgranulocyticdifferentiationinnb4acutepromyelocyticleukemiacells
AT alessandradimasi transcriptionalandmetabolicdissectionofatrainducedgranulocyticdifferentiationinnb4acutepromyelocyticleukemiacells